Shortage of ADHD drugs continues as patients scramble to find medication

There is a lingering shortage of medications to treat attention-deficit/hyperactivity disorder (ADHD), leading to challenges for patients in obtaining their prescriptions. The shortage, primarily affecting Adderall and other stimulants, is attributed to supply constraints, manufacturing issues, and increased demand during the pandemic. Patients may face delays in obtaining refills, impacting their ability to function, particularly in school. The shortage has prompted some individuals to switch medications or go without. Prescriptions for ADHD medications surged during the pandemic, particularly among young people and women. The shortage has persisted for over 18 months, with some manufacturers discontinuing production. Pharmacies manage the shortage by offering alternative strengths or recommending patients discuss alternative options with their providers. However, due to security concerns, pharmacies may be reluctant to disclose available stock. Overall, the shortage of ADHD medications is straining healthcare systems, pharmacies, patients, and providers.

To Learn More Visit Here